Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China

Hongbin Li, Meihao Guo, Zhen An, Jun Meng, Jing Jiang, Jie Song and Weidong Wu
Additional contact information
Hongbin Li: School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China
Meihao Guo: School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China
Zhen An: School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China
Jun Meng: School of Management, Xinxiang Medical University, Xinxiang 453003, Henan, China
Jing Jiang: School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China
Jie Song: School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China
Weidong Wu: School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China

IJERPH, 2020, vol. 17, issue 6, 1-13

Abstract: Metabolic associated fatty liver disease (MAFLD) is recognized as the liver disease component of metabolic syndrome, which is mainly related to insulin resistance and genetic susceptibility. It is the most prevalent chronic liver disease worldwide. With rapid lifestyle transitions, its prevalence worldwide is increasing, and tremendous challenges in controlling this pandemic are arising. The objective of this study was to investigate the prevalence and risk factors of MAFLD in rural areas of Xinxiang, Henan in 2017. We conducted a cross-sectional analysis of rural inhabitants aged 20–79 years in Xinxiang, Henan in 2017, using cluster random sampling ( N = 9140). Physical examinations were conducted at local clinics from April to June 2017. After overnight fasting, all participants underwent physical examinations, blood routine tests, biochemical examinations, and liver ultrasound and completed questionnaires. We investigated the crude and age-adjusted MAFLD prevalence and analyzed the characteristics of those with, and without, MAFLD, using logistic regression. Approximately 2868 (31.38%) participants were diagnosed with MAFLD. The overall age-adjusted MAFLD prevalence was 29.85% (men: 35.36%; women: 26.49%). The MAFLD prevalence increased with age, and peaked at the 50–59-year age group, and then began to decline. Higher body mass index, waist circumference, percentage of lymphocytes, levels of hemoglobin, platelet count, triglyceride, fasting plasma glucose, and serum uric acid were independently and positively correlated with MAFLD; In contrary, active physical activity and high-density lipoprotein cholesterol were negatively correlated with MAFLD. In summary, the MAFLD prevalence in the study population was 29.85%. Higher body mass index, waist circumference, percentage of lymphocytes, levels of hemoglobin, platelet count, triglyceride, fasting plasma glucose, and serum uric acid were risk factors for MAFLD.

Keywords: metabolic associated fatty liver disease; prevalence; risk factors; blood routine test; biochemical examination (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.mdpi.com/1660-4601/17/6/1818/pdf (application/pdf)
https://www.mdpi.com/1660-4601/17/6/1818/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:17:y:2020:i:6:p:1818-:d:331251

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().